Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000734398 | SCV000862537 | likely benign | not specified | 2018-07-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000866712 | SCV001007844 | benign | Autosomal recessive polycystic kidney disease | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Al Jalila Children’s Genomics Center, |
RCV001731915 | SCV001984627 | likely benign | Polycystic kidney disease 4 | 2019-12-26 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000734398 | SCV002033876 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001796201 | SCV002035383 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000866712 | SCV002078099 | likely benign | Autosomal recessive polycystic kidney disease | 2017-05-10 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003965549 | SCV004784535 | likely benign | PKHD1-related disorder | 2021-05-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |